INBX Inhibrx Biosciences, Inc.

Fundamentals / CIK 0002007919 / USD

Inhibrx Biosciences, Inc. reported $1.30M in revenue and a net loss of $141.7M for the fiscal year ended December 31, 2025 (up 550.0% year over year), with a -9671.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INBX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$1.69B$844.4M$0-$369.1MFY 2023 Revenue: $1.80MFY 2023 Net Income: -$241.4M2023FY 2024 Revenue: $200KFY 2024 Net Income: $1.69B2024FY 2025 Revenue: $1.30MFY 2025 Net Income: -$140.1M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $1.30M $200K $1.80M
Research & Development $113.0M $203.7M $191.6M
Total Operating Expenses $136.3M $331.6M $221.0M
Operating Income -$135.0M -$331.4M -$219.2M
EBITDA -$132.5M -$329.2M -$218.0M
Interest Expense $12.20M $13.49M $31.84M
Income Before Tax -$140.1M $1.69B -$239.7M
Income Tax Expense $2.0K $2.0K $3.0K
Net Income -$140.1M $1.69B -$241.4M
Basic EPS -$9.04 $114.01 -$20.48
Diluted EPS -$9.04 $112.62 -$20.48
Basic Shares Outstanding 15.5M 14.8M 11.8M
Diluted Shares Outstanding 15.5M 15.0M 11.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $2.00M $0 -- $0 $0 $1.30M $0 $100K
Research & Development $25.97M $23.90M $25.22M $25.35M $28.54M $22.27M $36.88M $33.37M
Total Operating Expenses $33.73M $32.15M $30.93M $30.92M $33.81M $28.69M $42.90M $50.03M
Operating Income -$31.73M -$32.15M -$30.93M -$30.92M -$33.81M -$27.39M -$42.90M -$49.93M
EBITDA -$31.22M -$31.63M -$30.39M -$30.36M -$33.23M -$26.73M -$42.23M -$49.24M
Interest Expense $8.75M $5.69M $3.51M $3.19M $3.18M $3.14M $2.69M $0
Income Before Tax -$38.73M -$36.65M -$33.44M -$32.83M -$35.26M -$28.65M -$43.31M -$47.87M
Income Tax Expense $0 $3.0K $0 $0 $0 $2.0K $0 $0
Net Income -$38.73M -$36.65M -$33.44M -$32.83M -$35.26M -$28.65M -$43.31M -$47.87M
Basic EPS -$2.46 -$2.34 -$2.15 -- -$2.28 -$1.85 -$2.80 --
Diluted EPS -$2.46 -$2.34 -$2.15 -- -$2.28 -$1.85 -$2.80 --
Basic Shares Outstanding 15.7M 15.7M 15.6M -- 15.5M 15.5M 15.5M --
Diluted Shares Outstanding 15.7M 15.7M 15.6M -- 15.5M 15.5M 15.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $124.2M $152.6M $277.9M
Cash & Short-Term Investments $124.2M $152.6M $277.9M
Other Current Assets $183K $382K $366K
Total Current Assets $132.8M $160.4M $295.4M
Property, Plant & Equipment, Net $3.73M $6.20M $6.42M
Other Non-Current Assets $4.38M $6.83M $3.16M
Total Non-Current Assets $13.65M $20.37M $12.54M
Total Assets $146.5M $180.8M $307.9M
Accounts Payable $5.94M $9.24M $10.95M
Total Current Liabilities $33.80M $40.73M $56.31M
Long-Term Debt $100.6M $0 $207.0M
Total Non-Current Liabilities $104.7M $6.45M $208.1M
Total Liabilities $138.5M $47.18M $264.4M
Total Debt (incl. Leases) $107.0M $8.05M $210.1M
Common Stock $1.0K $1.0K $5.0K
Retained Earnings -$246.2M -$106.1M -$613.7M
Total Stockholders' Equity $7.99M $133.6M $43.50M
Total Equity $7.99M $133.6M $43.50M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $199.5M $133.3M $161.7M $124.2M $153.1M $186.6M $216.5M $152.6M
Cash & Short-Term Investments $199.5M $133.3M $161.7M $124.2M $153.1M $186.6M $216.5M $152.6M
Other Current Assets $346K $574K $262K $183K $410K $283K $269K $382K
Total Current Assets $206.9M $142.2M $171.3M $132.8M $161.4M $194.0M $223.4M $160.4M
Property, Plant & Equipment, Net $2.17M $2.69M $3.20M $3.73M $4.31M $4.88M $5.55M $6.20M
Other Non-Current Assets $7.20M $4.77M $4.38M $4.38M $5.74M $6.81M $6.80M $6.83M
Total Non-Current Assets $13.42M $12.01M $12.63M $13.65M $16.05M $18.15M $19.25M $20.37M
Total Assets $220.3M $154.2M $184.0M $146.5M $177.5M $212.1M $242.6M $180.8M
Accounts Payable $8.37M $9.80M $8.76M $5.94M $6.77M $8.29M $8.89M $9.24M
Total Current Liabilities $27.30M $28.06M $26.51M $33.80M $35.98M $38.94M $43.64M $40.73M
Long-Term Debt $276.7M $176.3M $175.0M $100.6M $99.92M $99.28M $98.65M $0
Total Non-Current Liabilities $278.9M $179.1M $178.5M $104.7M $104.7M $104.6M $104.6M $6.45M
Total Liabilities $306.2M $207.2M $205.0M $138.5M $140.6M $143.6M $148.2M $47.18M
Total Debt (incl. Leases) $281.4M $181.6M $180.9M $107.0M $106.9M $106.8M $106.5M $8.05M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$355.0M -$316.3M -$279.6M -$246.2M -$213.4M -$178.1M -$149.4M -$106.1M
Total Stockholders' Equity -$85.88M -$52.98M -$21.04M $7.99M $36.83M $68.56M $94.44M $133.6M
Total Equity -$85.88M -$52.98M -$21.04M $7.99M $36.83M $68.56M $94.44M $133.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$140.1M $1.69B -$241.4M
Depreciation & Amortization $2.48M $2.29M $1.19M
Stock-Based Compensation $11.14M $58.52M $24.85M
Change in Receivables $200K -$185K -$535K
Change in Payables -$3.30M $17.90M $2.11M
Operating Cash Flow -$129.8M -$194.4M -$193.3M
Capital Expenditure -$31K -$2.60M -$4.59M
Free Cash Flow -$129.8M -$197.0M -$197.9M
Investing Cash Flow -$28K -$2.60M -$4.59M
Financing Cash Flow $101.4M $71.68M $202.0M
Net Change in Cash -$28.38M -$125.3M $4.06M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$38.73M -$36.65M -$33.44M -$32.83M -$35.26M -$28.65M -$43.31M -$47.87M
Depreciation & Amortization $514K $523K $537K $564K $582K $662K $675K $689K
Stock-Based Compensation $3.34M $3.10M $2.65M $2.74M $3.17M $2.77M $2.45M $2.98M
Change in Receivables $0 $0 $0 $0 $81K -$81K $200K -$85K
Change in Payables -$1.40M $1.01M $2.82M -$829K -$1.52M -$600K -$353K -$3.12M
Operating Cash Flow -$34.60M -$29.92M -$38.03M -$30.12M -$33.82M -$29.95M -$35.90M -$43.72M
Capital Expenditure -$29K $0 $0 $0 -$10K $0 -$21K -$16K
Free Cash Flow -$34.63M -$29.92M -$38.03M -$30.12M -$33.83M -$29.95M -$35.92M -$43.74M
Investing Cash Flow -$29K $0 $0 $0 -$7.0K $0 -$21K -$16K
Financing Cash Flow $100.8M $1.60M $75.46M $1.25M $352K $0 $99.84M $0
Net Change in Cash $66.12M -$28.31M $37.44M -$28.87M -$33.48M -$29.95M $63.92M -$43.74M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Operating Margin -10386.5% -165724.0% -12178.9%
Net Profit Margin -10773.5% 843786.0% -13408.9%
Return on Equity (ROE) -1752.2% 1263.3% -554.8%
Return on Assets (ROA) -95.6% 933.6% -78.4%
Current Ratio 3.93x 3.94x 5.25x
Quick Ratio 3.68x 3.75x 4.94x
Debt to Equity 13.39x 0.06x 4.83x
Revenue Growth (YoY) +550.0% -88.9% --
Net Income Growth (YoY) -108.3% -- --
EPS Growth (YoY) -107.9% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -10386.5% -11002.1% -11929.6% -150262.0% -165724.0%
Net Profit Margin -- -- -- -10773.5% -11077.6% -11692.4% 861485.5% 843786.0%
Return on Equity (ROE) -- -- -- -1752.2% -421.1% -238.8% 1824.4% 1263.3%
Return on Assets (ROA) -64.3% -89.6% -70.8% -95.6% -87.4% -77.2% 710.1% 933.6%
Current Ratio 7.58x 5.07x 6.46x 3.93x 4.49x 4.98x 5.12x 3.94x
Quick Ratio 7.31x 4.75x 6.10x 3.68x 4.25x 4.79x 4.96x 3.75x
Debt to Equity -- -- -- 13.39x 2.90x 1.56x 1.13x 0.06x
Revenue Growth (YoY) -- -100.0% -- -100.0% -- +1200.0% -- --
Net Income Growth (YoY) -- -- -- -- -- -101.5% -- --
EPS Growth (YoY) -- -- -- -- -- -101.5% -- --
Source: SEC EDGAR CompanyFacts (CIK 0002007919) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:27 UTC · Open in terminal